Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer.
Cancer Cell
; 41(11): 1838-1840, 2023 11 13.
Article
em En
| MEDLINE
| ID: mdl-37863065
ABSTRACT
Patients diagnosed with lung cancer (LC) exhibit increased susceptibility to SARS-CoV-2 infection. Rodilla et al. monitor the levels of plasma anti-nucleocapsid antibodies within a cohort of fully vaccinated LC patients and reveal that the actual infection rate is nearly twice the documented rate, indicating a significant prevalence of unreported cases.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
COVID-19
/
Neoplasias Pulmonares
Limite:
Humans
Idioma:
En
Revista:
Cancer Cell
Ano de publicação:
2023
Tipo de documento:
Article